95 related articles for article (PubMed ID: 15068000)
41. Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?
Aloman C; Wands JR
Hepatology; 2003 Dec; 38(6):1584-7. PubMed ID: 14655682
[No Abstract] [Full Text] [Related]
42. Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.
Aizawa M; Tsubota A; Fujise K; Tatsuzawa K; Kono M; Hoshina S; Tajiri H
J Med Virol; 2011 Jun; 83(6):953-61. PubMed ID: 21503906
[TBL] [Abstract][Full Text] [Related]
43. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.
Limquiaco JL; Wong J; Wong VW; Wong GL; Tse CH; Chan HY; Kwan KY; Lai PB; Chan HL
J Med Virol; 2009 Feb; 81(2):224-9. PubMed ID: 19107976
[TBL] [Abstract][Full Text] [Related]
44. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
Liang Y; Jiang J; Su M; Liu Z; Guo W; Huang X; Xie R; Ge S; Hu J; Jiang Z; Zhu M; Wong VW; Chan HL
Aliment Pharmacol Ther; 2011 Aug; 34(3):344-52. PubMed ID: 21671967
[TBL] [Abstract][Full Text] [Related]
45. Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
Sung JJ; Lai JY; Zeuzem S; Chow WC; Heathcote EJ; Perrillo RP; Brosgart CL; Woessner MA; Scott SA; Gray DF; Gardner SD
J Hepatol; 2008 May; 48(5):728-35. PubMed ID: 18329126
[TBL] [Abstract][Full Text] [Related]
46. Practical management of chronic hepatitis B infection.
Tsai NC
Semin Liver Dis; 2004; 24 Suppl 1():71-6. PubMed ID: 15192804
[TBL] [Abstract][Full Text] [Related]
47. [Hepatitis B (acute and chronic)].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Jul; 93(31-32):1227-33; quiz 1234, 1261. PubMed ID: 15453144
[No Abstract] [Full Text] [Related]
48. [Viral hepatitis B/C and HIV. Therapy of double infections].
Mauss S
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():21-5. PubMed ID: 15011579
[TBL] [Abstract][Full Text] [Related]
49. Drug therapy for hepatitis B.
Regev A; Schiff ER
Adv Intern Med; 2001; 46():107-35. PubMed ID: 11147250
[TBL] [Abstract][Full Text] [Related]
50. Viread, Epivir and Ziagen combination: failure in naïve patients with a once-daily regimen.
Berger DS
Posit Aware; 2003; 14(5):51-2. PubMed ID: 14679946
[No Abstract] [Full Text] [Related]
51. Pradefovir, a liver-targeted prodrug of adefovir against HBV infection.
Tillmann HL
Curr Opin Investig Drugs; 2007 Aug; 8(8):682-90. PubMed ID: 17668370
[TBL] [Abstract][Full Text] [Related]
52. [Active prevention and treatment of superinfection with HBV, HCV and HIV].
Zhuang H; Zhou YH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):294-5. PubMed ID: 15498237
[No Abstract] [Full Text] [Related]
53. Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA.
Vere Hodge A
IDrugs; 2003 Jun; 6(6):515-7. PubMed ID: 12861974
[No Abstract] [Full Text] [Related]
54. New drug for exposure to HIV goes on trial.
Nurs Stand; 1994 Apr 6-12; 8(28):15. PubMed ID: 8003408
[No Abstract] [Full Text] [Related]
55. HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.
Erion MD; Bullough DA; Lin CC; Hong Z
Curr Opin Investig Drugs; 2006 Feb; 7(2):109-17. PubMed ID: 16499280
[TBL] [Abstract][Full Text] [Related]
56. Treatment of chronic hepatitis B in the HIV-infected patient.
Thio CL
Hopkins HIV Rep; 2003 Jul; 15(4):9, 12. PubMed ID: 14696564
[No Abstract] [Full Text] [Related]
57. Chronic hepatitis B infection in sub-Saharan Africa: a grave challenge and a great hope.
Stockdale AJ; Geretti AM
Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):421-2. PubMed ID: 26065660
[No Abstract] [Full Text] [Related]
58. [The guideline of prevention and treatment for chronic hepatitis B (2010 version)].
Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Apr; 32(4):405-15. PubMed ID: 21569677
[No Abstract] [Full Text] [Related]
59. [Persistent attention on chronic hepatitis B clinical study].
Hou JL; Fan R; Sun J
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):161-3. PubMed ID: 23967732
[No Abstract] [Full Text] [Related]
60. Combination Therapy for Chronic Hepatitis B: Current Indications.
Paul N; Han SH
Curr Hepat Rep; 2011 Jun; 10(2):98-105. PubMed ID: 21654909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
